Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.
[This corrects the article DOI: 10.1371/journal.pone.0166415.].
Main Author: | PLOS ONE Staff |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5313219?pdf=render |
Similar Items
-
An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.
by: Jing Lu, et al.
Published: (2016-01-01) -
Generation of an apoptotic intracellular peptide by γ-secretase cleavage of Alzheimer's amyloid β protein precursor
by: Passer, B, et al.
Published: (2000) -
Correction: Acute and Chronic Sustained Hypoxia Do Not Substantially Regulate Amyloid-β Peptide Generation In Vivo.
by: PLOS ONE Staff
Published: (2017-01-01) -
Conformational Changes and Unfolding of β-Amyloid Substrates in the Active Site of γ-Secretase
by: Jakub Jakowiecki, et al.
Published: (2024-02-01) -
α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP
by: Roberts, HL, et al.
Published: (2017)